| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Hanish Arnold C serves as a Director at DCOY and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 6 buys and 6 sells.
Historically, Hanish Arnold C's trades have earned a below-average insider score of 46/100 across 5 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of -30.1%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | OMER Omeros Corporation | Director | Sale+OE | 15,000 | $18.81 | $282,094.00 | - | - | - | |
| Dec 30, 2025 | DCOY Salarius Pharmaceuticals, Inc. | Director | Sell | 27 | $0.64 | $17.27 | -100% | -13.1% | - | |
| Nov 20, 2025 | DCOY Salarius Pharmaceuticals, Inc. | Director | Buy | 5,000 | $0.75 | $3,740.50 | +33,333% | +1.3% | - | |
| May 22, 2023 | OMER Omeros Corp | Director | Sale+OE | 5,000 | $6.46 | $32,300.00 | - | -43.0% | -47.4% | |
| Jun 3, 2022 | DCOY Salarius Pharmaceuticals, Inc. | - | Buy | 28,000 | $0.18 | $5,152.00 | +152.6% | +17.0% | -65.2% | |
| Aug 10, 2021 | DCOY Salarius Pharmaceuticals, Inc. | - | Buy | 7,000 | $0.88 | $6,167.00 | +61.7% | -6.3% | -72.5% | |
| Aug 21, 2020 | DCOY Salarius Pharmaceuticals, Inc. | - | Buy | 4,000 | $0.98 | $3,920.00 | +54.4% | - | - | |
| Feb 11, 2020 | DCOY Salarius Pharmaceuticals, Inc. | Director | Buy | 4,350 | $1.15 | $5,002.50 | +145.0% | - | - | |
| Nov 25, 2019 | DCOY Salarius Pharmaceuticals, Inc. | Director | Buy | 3,000 | $3.59 | $10,770.00 | +100.0% | - | - |